Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 937 of 1,261
  1. US 8101630

    Extended release opioid abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  2. US 8101579

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  3. US 8101198

    Osteogenic enhancer composition

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  4. US 8101380

    Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  5. US 8101382

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  6. US 8101186

    Peptides that block the binding of IgG to FcRn

    Syntonix Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  7. US 8101572

    Methods for promoting wound healing and/or reducing scar formation

    Arizona Board of Regents, A Corporate Body Organized Under Arizona Law · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  8. US 8101584

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  9. US 8101739

    Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  10. US 8101742

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  11. US 8101740

    Positron emission tomography probes for imaging immune activation and selected cancers

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  12. US 8101712

    Purification processes for echinocandin-type compounds

    TEVA Gyógyszergyár Zártkör{acute over ())}{acute over (})}úen M{acute over ())}{acute over (})}úköd{acute over ())}{acute over (})}ó Részvénytársaság · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  13. US 8097759

    Inflammatory cytokine release inhibitor

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  14. US 8097636

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  15. US 8097695

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  16. US 8097737

    Process for production of optically active amine derivatives

    Takeda Pharmaceutical Company Limited · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  17. US 8097455

    System and method for forming skeletal muscle constructs having functional tissue interfaces

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  18. US 8097606

    Antiglucocorticoids for the treatment of catatonia

    Corcept Therapeutics Incorporated · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  19. US 8097701

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  20. US 8097612

    Compositions and methods relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  21. US 8097630

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  22. US 8097713

    Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  23. US 8097610

    Derivative having PPAR agonistic activity

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  24. US 8093354

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.